These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23677190)

  • 21. Association of cognitive impairment and lesion volumes in multiple sclerosis--a MRI study.
    Yildiz M; Tettenborn B; Radue EW; Bendfeldt K; Borgwardt S
    Clin Neurol Neurosurg; 2014 Dec; 127():54-8. PubMed ID: 25459243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.
    Strober L; Englert J; Munschauer F; Weinstock-Guttman B; Rao S; Benedict RH
    Mult Scler; 2009 Sep; 15(9):1077-84. PubMed ID: 19556311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of methylprednisolone on emotional functioning of patients with multiple sclerosis].
    Kułakowska A; Drozdowski W; Halicka D; Kochanowicz J; Braszko JJ
    Pol Merkur Lekarski; 2002 Sep; 13(75):200-3. PubMed ID: 12474570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological testing and event-related potentials in the assessment of cognitive performance in the patients with multiple sclerosis--a pilot study.
    Pokryszko-Dragan A; Zagrajek M; Slotwinski K; Gruszka E; Bilinska M; Podemski R
    Clin Neurol Neurosurg; 2009 Jul; 111(6):503-6. PubMed ID: 19233546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis.
    Vanotti S; Cores EV; Eizaguirre B; Melamud L; Rey R; Villa A
    Arq Neuropsiquiatr; 2013 Jun; 71(6):357-61. PubMed ID: 23828523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Standards for sample composition and impairment classification in neuropsychological studies of multiple sclerosis.
    Benedict R
    Mult Scler; 2009 Jul; 15(7):777-8. PubMed ID: 19542261
    [No Abstract]   [Full Text] [Related]  

  • 29. Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.
    Edgar C; Jongen PJ; Sanders E; Sindic C; Goffette S; Dupuis M; Jacquerye P; Guillaume D; Reznik R; Wesnes K
    BMC Neurol; 2011 Jun; 11():68. PubMed ID: 21649910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PASAT in detecting cognitive impairment in relapsing-remitting MS.
    Rosti E; Hämäläinen P; Koivisto K; Hokkanen L
    Appl Neuropsychol; 2007; 14(2):101-12. PubMed ID: 17523884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wechsler Adult Intelligence Scale-Fourth Edition performance in relapsing-remitting multiple sclerosis.
    Ryan JJ; Gontkovsky ST; Kreiner DS; Tree HA
    J Clin Exp Neuropsychol; 2012; 34(6):571-9. PubMed ID: 22394018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    Ozakbas S; Ormeci B; Idiman E
    J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment.
    Portaccio E; Amato MP; Bartolozzi ML; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
    J Neurol Sci; 2006 Jun; 245(1-2):195-9. PubMed ID: 16631794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuropsychological evaluation and psychopathology of multiple sclerosis].
    Defer G
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1128-34. PubMed ID: 11787345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis.
    Bellmann-Strobl J; Wuerfel J; Aktas O; Dörr J; Wernecke KD; Zipp F; Paul F
    Neurology; 2009 Nov; 73(20):1624-7. PubMed ID: 19917984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients.
    Tsivgoulis G; Triantafyllou N; Papageorgiou C; Evangelopoulos ME; Kararizou E; Sfagos C; Vassilopoulos D
    Acta Neurol Scand; 2007 Jan; 115(1):67-72. PubMed ID: 17156268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical assessment of the course of relapsing-remitting multiple sclerosis in patients treated with interferon beta].
    Pokryszko-Dragan A; Bilińska M; Gruszka E; Dubik-Jezierzańska M
    Pol Merkur Lekarski; 2005 Nov; 19(113):654-8. PubMed ID: 16498805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple sclerosis and cognitive decline: is ApoE-4 a surrogate marker?
    Carmona O; Masuet C; Santiago O; Alía P; Moral E; Alonso-Magdalena L; Casado V; Arbizu T
    Acta Neurol Scand; 2011 Oct; 124(4):258-63. PubMed ID: 21208197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of glatiramer acetate on spasticity in previously interferon-beta-treated and treatment-naive patients with relapsing-remitting multiple sclerosis: a prospective, nonrandomized, open-label, uncontrolled, observational pilot study.
    Meca-Lallana JE; de Mingo-Casado P; Amorin-Díaz M; Martínez-Navarro ML; Barreiro AF
    Clin Ther; 2010 Jun; 32(6):1061-6. PubMed ID: 20637960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive impairment after three decades of multiple sclerosis.
    Smestad C; Sandvik L; Landrø NI; Celius EG
    Eur J Neurol; 2010 Mar; 17(3):499-505. PubMed ID: 20050887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.